← 返回专利悬崖列表
CAS 153221-23-9
(1S,3R,6S,7S,9R,12S)-6-(but-3-en-1-yl)-12-[(tert-butyldimethylsilyl)oxy]-1-hydroxy-7,11,14,14-tetramethyl-9-[(triethylsilyl)oxy]-5-oxatricyclo[8.3.1.0(3,7)]tetradec-10-ene-2,4-dione
登记编号：(trans-XV)101438-11-a
应用背景（按来源药适应症）
乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate
来源药（使用该中间体的合成路线）
| 品种 | 梯队 | 到期年 |
|---|---|---|
| Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylate | Tier C · 观察 / 贸易 | - |
合成路线中的位置（上下游链）
按路线登记顺序排列，左→右为合成方向；高亮为当前 CAS，其余可点击跳转对应档案。
(2R,4R,5S)-4,10,11,11-tetramethyltricyclo[5.3.1.0(1,5)]undec-9-ene-2,5-diol→(2R,4R,5S)-4,10,11,11-tetramethyl-2-[(triethylsilyl)oxy]tricyclo[5.3.1.0(1,5)]undec-9-en-5-ol→(1R,4R,6R,9S)-9-[(tert-butyldimethylsilyl)oxy]-4,8,11,11-tetramethyl-6-[(triethylsilyl)oxy]bicyclo[5.3.1]undec-7-en-3-one→4-Pentenal→(1S,2R,3S,4R,6R,9S)-9-[(tert-butyldimethylsilyl)oxy]-4-[(1S)-1-hydroxypent-4-en-1-yl]-4,8,11,11-tetramethyl-6-[(triethylsilyl)oxy]bicyclo[5.3.1]undec-7-ene-2,3-diol→(1R,4R,6R,9S)-9-[(tert-butyldimethylsilyl)oxy]-4-[(1S)-1-hydroxypent-4-en-1-yl]-4,8,11,11-tetramethyl-6-[(triethylsilyl)oxy]bicyclo[5.3.1]undec-7-en-3-one→(1S)-1-[(1R,4R,6R,9S)-9-[(tert-butyldimethylsilyl)oxy]-4,8,11,11-tetramethyl-3-oxo-6-[(triethylsilyl)oxy]bicyclo[5.3.1]undec-7-en-4-yl]pent-4-en-1-yl propanoate→7,7-dimethyl-1-[(oxaziridine-2-sulfonyl)methyl]bicyclo[2.2.1]heptan-2-one→(1S)-1-[(1S,2R,4R,6R,9S)-9-[(tert-butyldimethylsilyl)oxy]-2-hydroxy-4,8,11,11-tetramethyl-3-oxo-6-[(triethylsilyl)oxy]bicyclo[5.3.1]undec-7-en-4-yl]pent-4-en-1-yl propanoate→(1S,2R,3S,7S,8R,10R,13S)-7-(but-3-en-1-yl)-13-[(tert-butyldimethylsilyl)oxy]-2-hydroxy-8,12,15,15-tetramethyl-10-[(triethylsilyl)oxy]-4,6-dioxatricyclo[9.3.1.0(3,8)]pentadec-11-en-5-one→(1S,3S,7S,8R,10R,13S)-7-(but-3-en-1-yl)-13-[(tert-butyldimethylsilyl)oxy]-8,12,15,15-tetramethyl-10-[(triethylsilyl)oxy]-4,6-dioxatricyclo[9.3.1.0(3,8)]pentadec-11-ene-2,5-dione→(1S,3S,6S,7R,9R,12S)-6-(but-3-en-1-yl)-12-[(tert-butyldimethylsilyl)oxy]-3-hydroxy-7,11,14,14-tetramethyl-9-[(triethylsilyl)oxy]-5-oxatricyclo[8.3.1.0(3,7)]tetradec-10-ene-2,4-dione→(1S,6S,7S,9R,12S)-6-(but-3-en-1-yl)-12-[(tert-butyldimethylsilyl)oxy]-2-hydroxy-7,11,14,14-tetramethyl-9-[(triethylsilyl)oxy]-5-oxatricyclo[8.3.1.0(3,7)]tetradeca-2,10-dien-4-one→(1S,3R,6S,7S,9R,12S)-6-(but-3-en-1-yl)-12-[(tert-butyldimethylsilyl)oxy]-7,11,14,14-tetramethyl-9-[(triethylsilyl)oxy]-5-oxatricyclo[8.3.1.0(3,7)]tetradec-10-ene-2,4-dione→(1S,3S,6S,7S,9R,12S)-6-(but-3-en-1-yl)-12-[(tert-butyldimethylsilyl)oxy]-7,11,14,14-tetramethyl-9-[(triethylsilyl)oxy]-5-oxatricyclo[8.3.1.0(3,7)]tetradec-10-ene-2,4-dione→(1S,3R,6S,7S,9R,12S)-6-(but-3-en-1-yl)-12-[(tert-butyldimethylsilyl)oxy]-1-hydroxy-7,11,14,14-tetramethyl-9-[(triethylsilyl)oxy]-5-oxatricyclo[8.3.1.0(3,7)]tetradec-10-ene-2,4-dione→(1S,3S,6S,7S,9R,12S)-6-(but-3-en-1-yl)-12-[(tert-butyldimethylsilyl)oxy]-1-hydroxy-7,11,14,14-tetramethyl-9-[(triethylsilyl)oxy]-5-oxatricyclo[8.3.1.0(3,7)]tetradec-10-ene-2,4-dione→(1S,2S,3R,6S,7S,9R,12S)-6-(but-3-en-1-yl)-12-[(tert-butyldimethylsilyl)oxy]-1,2-dihydroxy-7,11,14,14-tetramethyl-9-[(triethylsilyl)oxy]-5-oxatricyclo[8.3.1.0(3,7)]tetradec-10-en-4-one→(1S,5S,6R,9S,10S,12R,15S)-9-(but-3-en-1-yl)-15-[(tert-butyldimethylsilyl)oxy]-10,14,17,17-tetramethyl-12-[(triethylsilyl)oxy]-2,4,8-trioxatetracyclo[11.3.1.0(1,5).0(6,10)]heptadec-13-ene-3,7-dione
本站可供应的对应中间体
目录暂未收录该靶点的在售中间体 —— 可直接发起询价，需求会进入撮合池。
本页为中间体 CAS 注册档案：同 CAS 的多条路线登记已合并；后续供应商报价与买方需求以该 CAS 为主键撮合。